Clinical Trial

Rapid Whole Genome Sequencing Study

Study acronym: rWGS
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Rapid Whole Genome Sequencing (rWGS) has proven to provide much faster diagnoses than traditional clinical testing, including clinical Whole Exome Sequencing (WES) and standard Whole Genome Sequencing (WGS). This collaborative study seeks to provide rWGS as a research test to additional pediatric hospitals nationwide to assist in the rapid diagnosis of acutely ill children suspected of a genetic condition. The study will examine diagnosis rates, changes in clinical care as a result of a genetic diagnosis, and health economics including potential cost-effectiveness of rWGS. This study will also serve as a biorepository for future research on samples and data generated from genomic sequencing.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2017-12-27; most recent amendment 2021-12-07.
Trial Details
NCT Number NCT03385876
Lead Sponsor Rady Pediatric Genomics & Systems Medicine Institute
Conditions Genetic Diseases, Genetic Syndrome
Enrollment 100,000 participants
Start Date 2017-08-29
Primary Completion 2050-12-31 (estimated)
Study Completion 2050-12-31 (estimated)
Updated on ClinicalTrials.gov 2021-12-23